ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,168.66
-0.14%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Meridian Bioscience Inc (VIVO)

  7. Meridian Bioscience Inc (VIVO) News

Meridian Bioscience (VIVO)

Meridian Bioscience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VIVO
DateTimeSourceHeadlineSymbolCompany
13/02/202321:32Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:VIVOMeridian Bioscience Inc
09/02/202316:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VIVOMeridian Bioscience Inc
09/02/202313:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VIVOMeridian Bioscience Inc
06/02/202311:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:34Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:31Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:21Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:15Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:12Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:12Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202319:11Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202319:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202319:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202319:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202319:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202319:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202319:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202319:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202318:56PR Newswire (US)SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian BioscienceNASDAQ:VIVOMeridian Bioscience Inc
31/01/202316:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202314:41Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:VIVOMeridian Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:VIVO

Your Recent History

LSE
NG.
National Grid
LSE
VAST
Vast Resources
LSE
LLOY
Lloyds Banking
LSE
POS
Plexus
LSE
CUSN
Cornish Metals
LSE
OPTI
Optibiotix Health
LSE
BARC
Barclays
LSE
FDEV
Frontier Developments
LSE
BOO
Boohoo
LSE
GDR
Genedrive
LSE
IQE
Iqe
LSE
TEK
Tekcapital
LSE
GOLD
LSE
AET
Afentra
LSE
ITV
Itv
LSE
HUM
Hummingbird Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved